<DOC>
	<DOCNO>NCT01800617</DOCNO>
	<brief_summary>The purpose study test new thyroid hormone preparation . The thyroid gland produce two thyroid hormone : mostly T4 small amount T3 . Thyroid hormone therapy hypothyroidism thyroid cancer generally provide use levothyroxine , synthetic form T4 . T4 convert active hormone T3 circulation . Therefore , researcher believe T3 level T4-treated patient may slightly low individual whose thyroid gland function normally . Symptoms hypothyroidism suggest occur possible T3 deficiency , although controversial . Studies T3 , add substitute T4 traditional levothyroxine regimen , generally show benefit T3 . However , still possible benefit see short duration action `` half-life '' T3 . This short-life make necessary dose T3 twice three time daily . Despite multiple daily dos T3 , T3 level therapy tend troubled peak trough . These peak associate symptom excessive thyroid hormone level . This study look TSH thyroid hormone level follow daily dose new preparation T3 may longer duration action liothyronine . This preparation T3 call Thyromax速 BCT303 . The investigator believe steady level T3 see take Thyromax速 . The investigator believe patient hypothyroidism use Thyromax速 correct dose produce normal TSH level , without produce symptom much thyroid hormone . The goal future study test whether Thyromax速 may potential treatment hypothyroidism , compare traditional levothyroxine therapy .</brief_summary>
	<brief_title>A Study T3 Therapy Patients With Hypothyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypothyroidism</mesh_term>
	<criteria>Hypothyroid patient take levothyroxine Age 1865 Able make weekly inperson visit Washington , D.C. Pregnancy lactation Chronic medical condition heart disease chronic medical condition lung disease ( e.g . asthma ) , kidney disease ( e.g . kidney failure ) , liver disease ( e.g . hepatitis ) , diabetes , cancer . Steroid medication estrogen , progesterone , estrogen progesterone related medication , testosterone , glucocorticoid Already take T3</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>